| Product Description |
|
While MRL Ltd.´s Grifola frondosa is not an extract of Grifola frondosa, the powder does contains both mycelium and primordia (young fruit body) cultivated into a biomass that is grown on a sterilised (autoclaved) substrate. This cultivation process ensures the powder is free from contamination by other fungi and that pesticides and heavy metals are absent. The cultivation system is proprietary, allowing for standardised production of Grifola frondosa.
|
| Warning |
The product is not intended to diagnose, treat, cure or prevent any disease.
|
| Nutrition Information |
Supplemental Facts Serving 2 Tablets
Amount Per Serving
Calories (K Cal) 3.8 kCal
Total Carbohydrate 800 mg
Dietary Fibre 82.8 mg
Protein 103 mg
Fat 15.2 mg
Grifola frondosa biomass 1000 mg
|
| Ingredients |
Each Tablet of Maitake-MRL contains:
Grifola frondosa-biomass powder 500 mg
Other Ingredients:
Microcrystalline Cellulose
Silica
Vegetable Magnesium Sterate
|
| Related Products |
|
Cordyceps MRL, Coriolus MRL, Reishi MRL, Triton MRL.
|
| © CopyRight |
|
MRL
|
| More |
United Kingdom based, MRL was founded in 1997 and develops mycology (mushroom nutrition) and non-mycology products as dietary supplements or "functional foods".
MRL utilises proprietary Japanese production technology to cultivate selected strains of the different mushrooms in California. The strains have been selected for their overall bioactivity and for their stability (purity). The cultivation process is in accordance with the California Organic Food Act of 1990.
These mushroom nutrition products are not extracts, but instead contain both the mycelium and primordia (young fruitbody) of the mushroom cultivated into a biomass on an edible, sterile (autoclaved substrate). The cultivation process ensures that the biomass is free from contamination by other fungi or bacteria and that heavy metals (pesticides) are not present.
Following cultivation, the biomass is dried, powdered and tableted to food grade Good Manufacturing Practice (GMP) standards.
|
